Surmodics IVD Launches Breakthrough MatrixGuard™ Diluent
Unlike other diluents that either are marginally effective at blocking
matrix interferences or alternatively block out true assay signal, MatrixGuard
Diluent achieves the goal of maximum blockade of matrix
interferences while simultaneously allowing the intended signal to be
maintained. MatrixGuard Diluent significantly reduces the risk of
false positives and has excellent three-year stability. Along with all
With the launch of MatrixGuard Diluent, we continue our
commitment to be a premier provider of assay components to improve
performance and manufacturability of immunoassays,” said
Surmodics IVD products immediately improve assay performance and manufacturability of assays by lowering backgrounds, increasing signal generation and providing longer shelf lives for immunoassay production. The addition of MatrixGuard Diluent augments the company’s leading portfolio of products, including:
- The Immunoassay Stabilizer family preserves the conformation and activity of dried proteins coated on a wide range of surfaces, keeping antibodies and antigens at peak performance for long durations. At the same time, the blocking mechanisms in these reagents reduce non-specific binding of interfering proteins to maximize assay sensitivity.
The StabilZyme® family provides unparalleled long-term
stability of protein conjugates at working strength concentrations.
Surmodicsformulations for HRP conjugates, AP conjugates and general protein applications ensure that assay developers have a complete set of tools to address the labile nature of each protein of interest.
- BioFX® TMB substrate family outperforms competitors for low background, stability and sensitivity with a variety of kinetic rate substrates. The one-component formulations provide optimal signal generation and longer shelf lives.
Tim Arens, 952-500-7000